Skip to main content
. 2020 Sep 8;6(10):1185–1191. doi: 10.1016/j.eng.2020.08.011

Fig. 2.

Fig. 2

The survival curves for clinical improvement, obvious absorption of pulmonary infection and the time of negative conversion of the viral nucleic acid test. (a) The survival curve with proportion of clinical improvement; (b) the obvious absorption of pulmonary infection by chest CT imaging; (c) the proportion with repeated negative viral nucleic acid test in 48 h by RT-PCR.